CXCR3 chemokine receptor enables local CD8+ T cell migration for the destruction of virus-infected cells

Immunity

Volumn 42, Issue 3, 2015, Pages 524-537

  Hickman, Heather D ^a   Reynoso, Glennys V ^a   Ngudiankama, Barbara F ^a   Cush, Stephanie S ^a   Gibbs, James ^a   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIGAND; CXCL10 PROTEIN, MOUSE; CXCL9 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; FLOW CYTOMETRY; IMMUNE RESPONSE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; ADOPTIVE TRANSFER; ANIMAL; CELL MOTION; CYTOTOXIC T LYMPHOCYTE; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; KERATINOCYTE; PATHOLOGY; POXVIRUS INFECTION; SIGNAL TRANSDUCTION; SKIN; TRANSGENIC MOUSE; TRANSPLANTATION; VIROLOGY; VIRUS LOAD;

ADOPTIVE TRANSFER; ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL10; CHEMOKINE CXCL9; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICE, TRANSGENIC; POXVIRIDAE INFECTIONS; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRAL LOAD;

EID: 84924935576     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.02.009     Document Type: Article

References (41)

1. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., et al. Interferon-inducible Tcell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated Tcells through selective high affinity binding to CXCR3. J.Exp. Med. 1998, 187:2009-2021.
2. Friedl P., Weigelin B. Interstitial leukocyte migration and immune function. Nat. Immunol. 2008, 9:960-969.
3. Gordon S.N., Cecchinato V., Andresen V., Heraud J.M., Hryniewicz A., Parks R.W., Venzon D., Chung H.K., Karpova T., McNally J., et al. Smallpox vaccine safety is dependent on Tcells and not B cells. J.Infect. Dis. 2011, 203:1043-1053.
4. Groom J.R., Luster A.D. CXCR3 in Tcell function. Exp. Cell Res. 2011, 317:620-631.
5. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 2011, 89:207-215.
6. Groom J.R., Richmond J., Murooka T.T., Sorensen E.W., Sung J.H., Bankert K., von Andrian U.H., Moon J.J., Mempel T.R., Luster A.D. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 2012, 37:1091-1103.
7. Guarda G., Hons M., Soriano S.F., Huang A.Y., Polley R., Martín-Fontecha A., Stein J.V., Germain R.N., Lanzavecchia A., Sallusto F. L-selectin-negative CCR7- effector and memory CD8+ Tcells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 2007, 8:743-752.
8. Harris T.H., Banigan E.J., Christian D.A., Konradt C., Tait Wojno E.D., Norose K., Wilson E.H., John B., Weninger W., Luster A.D., et al. Generalized Lévy walks and the role of chemokines in migration of effector CD8+ Tcells. Nature 2012, 486:545-548.
9. Henrickson S.E., von Andrian U.H. Single-cell dynamics of T-cell priming. Curr. Opin. Immunol. 2007, 19:249-258.
10. Hickman H.D., Takeda K., Skon C.N., Murray F.R., Hensley S.E., Loomis J., Barber G.N., Bennink J.R., Yewdell J.W. Direct priming of antiviral CD8+ Tcells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 2008, 9:155-165.
11. Hickman H.D., Bennink J.R., Yewdell J.W. From optical bench to cageside: intravital microscopy on the long road to rational vaccine design. Immunol. Rev. 2011, 239:209-220.
12. Hickman H.D., Li L., Reynoso G.V., Rubin E.J., Skon C.N., Mays J.W., Gibbs J., Schwartz O., Bennink J.R., Yewdell J.W. Chemokines control naive CD8+ Tcell selection of optimal lymph node antigen presenting cells. J.Exp. Med. 2011, 208:2511-2524.
13. Hickman H.D., Reynoso G.V., Ngudiankama B.F., Rubin E.J., Magadán J.G., Cush S.S., Gibbs J., Molon B., Bronte V., Bennink J.R., Yewdell J.W. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe 2013, 13:155-168.
14. Hokeness K.L., Deweerd E.S., Munks M.W., Lewis C.A., Gladue R.P., Salazar-Mather T.P. CXCR3-dependent recruitment of antigen-specificT lymphocytes to the liver during murine cytomegalovirus infection. J.Virol. 2007, 81:1241-1250.
15. Hsieh M.F., Lai S.L., Chen J.P., Sung J.M., Lin Y.L., Wu-Hsieh B.A., Gerard C., Luster A., Liao F. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J.Immunol. 2006, 177:1855-1863.
16. Hu J.K., Kagari T., Clingan J.M., Matloubian M. Expression of chemokine receptor CXCR3 on Tcells affects the balance between effector and memory CD8 T-cell generation. Proc. Natl. Acad. Sci. USA 2011, 108:E118-E127.
17. Huen A.C., Wells A. The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing. Adv. Wound Care (New Rochelle) 2012, 1:244-248.
18. Ip P.P., Liao F. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J.Immunol. 2010, 184:5705-5714.
19. Kastenmüller W., Brandes M., Wang Z., Herz J., Egen J.G., Germain R.N. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ Tcell responses in the lymph node. Immunity 2013, 38:502-513.
20. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J.Virol. 2005, 79:11457-11466.
21. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory Tcellhomeostasis and function during type 1 inflammation. Nat. Immunol. 2009, 10:595-602.
22. Kohlmeier J.E., Reiley W.W., Perona-Wright G., Freeman M.L., Yager E.J., Connor L.M., Brincks E.L., Cookenham T., Roberts A.D., Burkum C.E., et al. Inflammatory chemokine receptors regulate CD8(+) Tcell contraction and memory generation following infection. J.Exp. Med. 2011, 208:1621-1634.
23. Kurachi M., Kurachi J., Suenaga F., Tsukui T., Abe J., Ueha S., Tomura M., Sugihara K., Takamura S., Kakimi K., Matsushima K. Chemokine receptor CXCR3 facilitates CD8(+) Tcell differentiation into short-lived effector cells leading to memory degeneration. J.Exp. Med. 2011, 208:1605-1620.
24. Lämmermann T., Bader B.L., Monkley S.J., Worbs T., Wedlich-Söldner R., Hirsch K., Keller M., Förster R., Critchley D.R., Fässler R., Sixt M. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008, 453:51-55.
25. Lee B.J., Giannoni F., Lyon A., Yada S., Lu B., Gerard C., Sarawar S.R. Role of CXCR3 in the immune response to murine gammaherpesvirus 68. J.Virol. 2005, 79:9351-9355.
26. Lim J.K., Murphy P.M. Chemokine control of West Nile virus infection. Exp. Cell Res. 2011, 317:569-574.
27. Liu L., Zhong Q., Tian T., Dubin K., Athale S.K., Kupper T.S. Epidermal injury and infection during poxvirus immunization is crucial for thegeneration of highly protective Tcell-mediated immunity. Nat. Med. 2010, 16:224-227.
28. Mahalingam S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity Invivo. J.Virol. 1999, 73:1479-1491.
29. Mota B.E., Gallardo-Romero N., Trindade G., Keckler M.S., Karem K., Carroll D., Campos M.A., Vieira L.Q., da Fonseca F.G., Ferreira P.C., et al. Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus. PLoS ONE 2011, 6:e18924.
30. Mueller S.N., Hickman H.D. Invivo imaging of the Tcell response to infection. Curr. Opin. Immunol. 2010, 22:293-298.
31. + Tcells is dependent on integrin αV. Nat. Immunol. 2013, 14:949-958.
32. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the invivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 2003, 100:1885-1890.
33. Rot A. Neutrophil attractant/activation protein-1 (interleukin-8) induces invitro neutrophil migration by haptotactic mechanism. Eur. J. Immunol. 1993, 23:303-306.
34. Slütter B., Pewe L.L., Kaech S.M., Harty J.T. Lung airway-surveilling CXCR3(hi) memory CD8(+) Tcells are critical for protection against influenza A virus. Immunity 2013, 39:939-948.
35. Sung J.H., Zhang H., Moseman E.A., Alvarez D., Iannacone M., Henrickson S.E., de la Torre J.C., Groom J.R., Luster A.D., von Andrian U.H. Chemokine guidance of central memory Tcells is critical for antiviral recall responses in lymph nodes. Cell 2012, 150:1249-1263.
36. Taqueti V.R., Grabie N., Colvin R., Pang H., Jarolim P., Luster A.D., Glimcher L.H., Lichtman A.H. T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. J.Immunol. 2006, 177:5890-5901.
37. Thapa M., Carr D.J. CXCR3 deficiency increases susceptibility togenital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J.Virol. 2009, 83:9486-9501.
38. Tscharke D.C., Karupiah G., Zhou J., Palmore T., Irvine K.R., Haeryfar S.M., Williams S., Sidney J., Sette A., Bennink J.R., Yewdell J.W. Identification of poxvirus CD8+ Tcell determinants to enable rational design and characterization of smallpox vaccines. J.Exp. Med. 2005, 201:95-104.
39. Wickham S., Lu B., Ash J., Carr D.J. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J.Neuroimmunol. 2005, 162:51-59.
40. Yates C.C., Whaley D., Kulasekeran P., Hancock W.W., Lu B., Bodnar R., Newsome J., Hebda P.A., Wells A. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am. J. Pathol. 2007, 171:484-495.
41. Yates C.C., Whaley D., Y-Chen A., Kulesekaran P., Hebda P.A., Wells A. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am. J. Pathol. 2008, 173:643-652.